Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.98
-0.30 (-4.12%)
At close: Jan 29, 2026, 4:00 PM EST
6.98
0.00 (0.00%)
After-hours: Jan 29, 2026, 4:10 PM EST
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $181.51 million as of January 29, 2026. Its market cap has decreased by -61.51% in one year.
Market Cap
181.51M
Enterprise Value
53.58M
1-Year Change
-61.51%
Ranking
Category
Stock Price
$6.98
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $181.51M, an increase of 9.30%. That is a compound annual growth rate of 4.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 189.31M | 0.97% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 203.09M |
| Context Therapeutics | 201.22M |
| Humacyte | 198.79M |
| Camp4 Therapeutics | 198.70M |
| Sagimet Biosciences | 198.06M |
| Surrozen | 197.40M |
| Opus Genetics | 195.17M |
| Zentalis Pharmaceuticals | 189.72M |